FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1242213 · Received November 19, 2008

Report

Report Number
2024168-2008-01185
Event Type
Injury
Date Received
November 19, 2008
Date of Event
September 9, 2008
Report Date
October 24, 2008
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS AND CONCLUSION SUMMATION - PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT. ANGINA AND STENOSIS, AS LISTED IN THE XIENCE V IFU, ARE KNOWN RISKS ASSOCIATED WITH CORONARY STENTING. THESE PT EFFECTS ARE NOT NECESSARILY AN INDICATION OF PROD QUALITY ISSUE. AS THERE WAS NO REPORTED DEVICE MALFUNCTION, THERE DOES NOT APPEAR TO BE ANY INDICATIONS OF A STENT DELIVERY SYS QUALITY PROBLEM. THE REPORTED PT ISSUE OF ANGINA APPEARS TO BE A RESULT OF THE RESTENOSIS AND THEREFORE REQUIRED ADD'L HOSPITALIZATION. A CONCLUSIVE ROOT CAUSE FOR ALL REPORTED PT ISSUES, AND THE RELATIONSHIP TO THE DEVICE CANNOT BE DETERMINED.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY/MEDICAL INTERVENTION. REPORTING RATIONALE: RESTENOSIS REQUIRING MEDICAL INTERVENTION. DEVICE ISSUE: NO DEVICE ISSUE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA TRIAL THAT A XIENCE V STENT WAS IMPLANTED IN 2007, IN THE PROXIMAL LAD. THE FOLLOWING YEAR, THE PT BEGAN TO EXPERIENCE CHEST PAIN/ANGINA. THE PT WAS HOSPITALIZED AND A DIAGNOSTIC CORONARY ANGIOGRAPHY WAS PERFORMED; HOWEVER, NO TREATMENT WAS PERFORMED AT THAT TIME. THREE MONTHS LATER, THE PT WAS HOSPITALIZED AGAIN FOR ANGIOGRAPHY WHICH RESULTED IN REVASCULARIZATION WITH THE DEPLOYMENT OF ANOTHER CO'S STENT DUE TO RESTENOSIS. NO ADD'L EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| R